Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-009924
Filing Date
2021-03-01
Accepted
2021-03-01 17:01:05
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K axsm-10k_20201231.htm   iXBRL 10-K 3311881
2 EX-23.1 axsm-ex231_120.htm EX-23.1 13574
3 EX-31.1 axsm-ex311_64.htm EX-31.1 18190
4 EX-31.2 axsm-ex312_65.htm EX-31.2 17745
5 EX-32.1 axsm-ex321_62.htm EX-32.1 4841
6 EX-32.2 axsm-ex322_63.htm EX-32.2 4838
7 GRAPHIC g4vlmlsfrvek000002.jpg GRAPHIC 32859
8 GRAPHIC g4vlmlsfrvek000001.jpg GRAPHIC 33846
  Complete submission text file 0001564590-21-009924.txt   10490296

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA axsm-20201231.xsd EX-101.SCH 63952
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axsm-20201231_cal.xml EX-101.CAL 55555
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axsm-20201231_def.xml EX-101.DEF 186680
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE axsm-20201231_lab.xml EX-101.LAB 511627
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axsm-20201231_pre.xml EX-101.PRE 384507
14 EXTRACTED XBRL INSTANCE DOCUMENT axsm-10k_20201231_htm.xml XML 1751799
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37635 | Film No.: 21698997
SIC: 2834 Pharmaceutical Preparations